Skip to main
SOLV

Solventum Corporation (SOLV) Stock Forecast & Price Target

Solventum Corporation (SOLV) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 45%
Hold 27%
Sell 0%
Strong Sell 9%

Bulls say

Solventum is expected to see growth in both its MedSurg and Dental segments, driven by ongoing demand for key products and expansion into new markets. The company's focus on digital capabilities and data science also positions it well for future growth and innovation within the healthcare industry. Furthermore, potential divestiture in non-core product areas could further optimize Solventum's portfolio and improve its financial performance. This, combined with potential M&A activity and pricing strategies, could result in increased revenue and margins for the company. However, there are some potential risks, such as competition and regulatory actions, that could impact Solventum's growth and stock performance. Overall, with a promising financial outlook and a strong product portfolio, Solventum appears to be a good investment opportunity for the long-term.

Bears say

Solventum is facing potential downsides in its key segments due to lower organic growth, slower improvement in operat

Solventum Corporation (SOLV) has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 45% recommend Buy, 27% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Solventum Corporation (SOLV) Forecast

Analysts have given Solventum Corporation (SOLV) a Buy based on their latest research and market trends.

According to 11 analysts, Solventum Corporation (SOLV) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Solventum Corporation (SOLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.